#50 What The July FDA Hearing Could Mean For Compounded Peptides
Streams straight from the publisher. PodNod never proxies or re-hosts episode audio.
The internet loves a scary headline, and “peptides placed in category two” might be the most misunderstood one yet. We’re Dr. Kylie Burton and Jessica Briecke, and we’re slowing the noise down to explain what’s actually happening with the FDA’s July 23–24 hearing and why it directly affects patient access to compounded peptides.
It started back in 2023 when compounding pharmacies pushed back against government regulation. What happened then and what's happening now revolves around the FDA's category 1 and category 2 classifications. These classifications affect our access to them.
What exactly do these classifications mean though? And what's the difference between the DEA and the FDA?
Inside this episode, we also tackle:
- 503A pharmacies
- 503C pharmacies
- The FDA hearing happening July 23 and 24th
- What peptides are getting reclassified
- Why this process will take longer than one weekend
Let's face the reality: when regulated access disappears, people will get pushed into the gray market with questionable sourcing and risky kitchen mixes. It's already bad enough. We don't want it to become worse.
If you care about peptide therapy, compounding pharmacy policy, and safe wellness options, hit play, share this with someone who’s seeing the misinformation, and leave a review so more people can find clear answers.
Where do you start with peptide therapy? What do you add next? If you're a go-getter, check out Dr. Kylie's new program AMPLIFY. You'll find it on the homepage of her website: drkylieburton.com
Ready to explore peptide therapy for yourself? Join through Jessica's platform at B2BwithJess.com/peptides or through Dr. Kylie's platform at drkylieburton.com/shop.
Want to offer peptide therapy in your business? Whether you're adding it to your existing practice or building something new, learn how to get started—and how we'll mentor you along the way—at drkylieburton.com/peptidesaffiliate. You can also get started through Jessica's platform at B2BwithJess.com.
Legal Disclaimer: This podcast is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before starting any new health protocol. Dr. Kylie Burton and Jessica Briecke are affiliates and may receive compensation for referrals. Individual results may vary.
You have the science. You have the tools. Now it's time to take the next step.
This is PepTalk: Peptides Unpacked—science made simple, re...
drkylieburton.com
drkylieburton.comB2BwithJess.com/peptides
b2bwithjess.comdrkylieburton.com/shop
drkylieburton.comdrkylieburton.com/peptidesaffiliate
drkylieburton.comB2BwithJess.com
b2bwithjess.com
- 0:00Why Peptides Get Misunderstood
- 0:20The FDA Hearing And The Panic
- 0:59FDA Category Two Versus DEA
- 5:20PCAC Review And What Happens Next
- 7:39Real-World Evidence Versus RCTs
- 13:11Gray Market Risks And Safe Access
- 14:37Where To Follow Updates